Advisor Group Holdings, Inc. Adc Therapeutics Sa Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 11,872 shares of ADCT stock, worth $18,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,872

Previous 11,872 -0.0%

Holding current value

$18,045

Previous $37,000 37.84%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.59 - $4.01 $2,590 - $4,010	1,000 Added 9.2%	11,872 $37,000
Q2 2024 Aug 13, 2024	BUY	$2.55 - $5.09 $7,323 - $14,618	2,872 Added 35.9%	10,872 $34,000
Q1 2024 May 10, 2024	SELL	$1.66 - $5.29 $9,960 - $31,740	-6,000 Reduced 42.86%	8,000 $35,000
Q4 2023 Feb 12, 2024	SELL	$0.47 - $1.79 $4,055 - $15,445	-8,629 Reduced 38.13%	14,000 $23,000
Q3 2023 Nov 13, 2023	BUY	$0.72 - $2.37 $8,254 - $27,172	11,465 Added 102.7%	22,629 $20,000
Q2 2023 Aug 10, 2023	BUY	$1.9 - $2.66 $3,195 - $4,474	1,682 Added 17.74%	11,164 $24,000
Q1 2023 May 12, 2023	BUY	$1.92 - $5.45 $5,564 - $15,794	2,898 Added 44.02%	9,482 $18,000
Q4 2022 Feb 10, 2023	BUY	$2.87 - $5.24 $3,808 - $6,953	1,327 Added 25.24%	6,584 $25,000
Q3 2022 Nov 14, 2022	SELL	$4.66 - $10.31 $1,053 - $2,330	-226 Reduced 4.12%	5,257 $25,000
Q2 2022 Aug 10, 2022	BUY	$5.96 - $14.99 $13,320 - $33,502	2,235 Added 68.81%	5,483 $44,000
Q1 2022 May 04, 2022	BUY	$13.28 - $20.03 $38,591 - $58,207	2,906 Added 849.71%	3,248 $47,000
Q3 2021 Nov 05, 2021	SELL	$20.45 - $30.0 $1,022 - $1,500	-50 Reduced 12.76%	342 $9,000
Q2 2021 Aug 02, 2021	BUY	$20.38 - $27.04 $4,300 - $5,705	211 Added 116.57%	392 $9,000
Q4 2020 Feb 10, 2021	BUY	$25.26 - $38.02 $404 - $608	16 Added 9.7%	181 $6,000
Q3 2020 Nov 12, 2020	SELL	$32.87 - $51.05 $460 - $714	-14 Reduced 7.82%	165 $5,000
Q2 2020 Aug 14, 2020	BUY	$29.65 - $46.81 $5,307 - $8,378	179 New	179 $8,000

Others Institutions Holding ADCT

# of Institutions

Shares Held

55M

Call Options Held

24.1K

Put Options Held

44.7K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $118M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Adc Therapeutics Sa Transaction History